Aside from the dubious legality of many CBD products, customers are presented with another significant problem. Until the FDA fully approves CBD oil as a medicine or supplement, the market will remain completely unregulated. This lack of scrutiny leaves manufacturers free to produce low-quality oils, which at best may have no effect, and at worst, may damage consumer health.
Although CBD and cannabis-based medicines are becoming more widely available, residents of certain states may still have some difficulty accessing it. For example, if you reside in a state with a CBD oil registry, you will need to suffer from one of the listed qualifying conditions and get approval from your doctor.
Remember only to buy CBD from a reputable brand and don’t be sucked in by low prices. You get what you pay for in the CBD world, and if the cost of a product seems too good to be true, it probably is.
Which CBD Products Are Approved by the FDA?
We have not included the specific details of CBD laws in individual states as they are continually being updated. If you want to know whether you need a written recommendation for CBD oil in your area, we recommend that you contact your local health department for further information.
At the time of writing, a total of 33 states have medical marijuana laws in place. If you are lucky enough to live in one of these states, you can apply for a medical card and get access to a whole range of different cannabis-based products.
If you live in a more liberal state, you may also find CBD in specialist stores. There have even been reports of the cannabinoid being sold at gas stations in some states! Whether these products are reliable or not is an entirely different matter, though.
Where Can You Buy CBD Oil Over the Counter?
However, while CBD companies and consumers are celebrating the new law, there is just one small catch. The Farm Bill also preserved the rights of the Food and Drug Administration (FDA) to regulate all cannabis-based products under the Food, Drug, and Cosmetic Act. So, while many companies state that their CBD is legal in all 50 states, this is not necessarily the case.
The only cannabidiol product which is currently approved by the FDA is Epidiolex. This medicine was developed by GW Pharmaceuticals and is licensed in the treatment of drug-resistant forms of epilepsy such as Dravet syndrome and Lennox-Gastaut syndrome. As the product has undergone rigorous testing, the FDA has deemed it safe and effective. Sadly, this is more than can be said for other forms of CBD.
The FDA will continue to facilitate the work of companies interested in appropriately bringing safe, effective, and quality products to market, including scientifically-based research concerning the medicinal uses of cannabis. Additional information concerning research on the medical use of cannabis is available from the National Institutes of Health, particularly the National Cancer Institute (NCI) and National Institute on Drug Abuse (NIDA).
17. Does the FDA object to the clinical investigation of cannabis for medical use?
Research and Expanded Access
Conducting clinical research using cannabis-related substances that are scheduled by the DEA often involves interactions with several federal agencies. This includes: a registration administered by the DEA; obtaining the cannabis for research from NIDA, within the National Institutes of Health, or another DEA-registered source; and review by the FDA of the IND or INAD application and research protocol. Additionally: